Completed NA INTERVENTIONAL 1-arm NCT03128723

A Study to Evaluate the Tolerance of an Acne Treatment in Sensitive Skin Subjects With Mild to Moderate Acne Vulgaris

A Single Center Clinical Study to Evaluate the Tolerance of an Acne Treatment in Sensitive Skin Subjects With Mild to Moderate Acne Vulgaris

Sponsor: Johnson & Johnson Consumer Inc. (J&JCI)

Conditions Acne Vulgaris

Interventions Acne Mask

Updated 9 times since 2017 Last updated: Aug 30, 2018 Started: Apr 30, 2017 Primary completion: Jun 8, 2017 Completion: Jun 8, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03128723, this NA trial focuses on Acne Vulgaris and remains completed. Sponsored by Johnson & Johnson Consumer Inc. (J&JCI), it has been updated 9 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Feb 2020 — Jan 2021 [monthly]

Completed NA
Sep 2018 — Feb 2020 [monthly]

Completed NA

▶ Show 4 earlier versions

Jun 2018 — Sep 2018 [monthly]

Completed NA
Aug 2017 — Jun 2018 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Jul 2017 — Aug 2017 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting
Jun 2017 — Jul 2017 [monthly]

Recruiting NA

First recorded

Apr 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Johnson & Johnson Consumer Inc. (J&JCI)

Data source: Johnson & Johnson Consumer and Personal Products Worldwide

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nashville, United States